Management of secondary hyperparathyroidism: The gap between diagnosis and treatment

American Journal of the Medical Sciences

Volumn 320, Issue 2, 2000, Pages 107-111

  Diaz Corte, C ^a   Cannata Andia, J B ^a  

^a Bone and Mineral Research Unit   (Spain)

Author keywords

Dialysis; Hyperparathyroidism; Renal osteodystrophy; Vitamin D

Indexed keywords

ALFACALCIDOL; CALCITRIOL; PARATHYROID HORMONE; VITAMIN D;

ARTICLE; CHRONIC KIDNEY FAILURE; DIALYSIS; DISEASE COURSE; DOSE RESPONSE; HORMONE ACTION; HORMONE RESISTANCE; HORMONE SUBSTITUTION; PARATHYROID FUNCTION; PARATHYROID HORMONE BLOOD LEVEL; PROPHYLAXIS; RENAL OSTEODYSTROPHY; SECONDARY HYPERPARATHYROIDISM; SPAIN; UREMIA;

EID: 0033843456     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200008000-00008     Document Type: Article

References (24)

1. Pathogenesis of secondary hyperparathyroidism
2. 2+ -sensing receptor from bovine parathyroid gland
3. Oral vitamin D or calcium carbonate in the prevention of renal bone disease?
4. 3H]1,25-dihydroxyvitamin D3 in the parathyroid glands of patients with renal failure
5. 1-alphahydroxyvitamin D3 derivatives in the treatment of renal bone diseases: Justification and optimal modalities of administration
6. Which is the preferred treatment of advanced hyperparathyroidism in a renal patient? I. Medical intervention is the primary option in the treatment of advanced hyperparathyroidism in chronic renal failure
7. Prevention, diagnosis and treatment of renal Osteodystrophy in Spain. Preliminary results from a multicentre enquire
8. The use of 1,25-dihydroxyvitamin D3 in early renal failure
9. A low-dose calcitriol prevents the rise in 1,84 iPTH without affecting serum calcium and phosphate in patients with moderate renal failure (prospective placebo-controlled multicentre trial)
10. Long-term low dose calcitriol treatment in predialysis chronic renal failure: Can it prevent hyperparathyroid bone disease?
11. Effect of alfacalcidiol on natural course of renal bone disease in mild to moderate renal failure
12. Disorders of bone and mineral metabolism after renal transplantation
13. Identification of risk factors on secondary hyperparathyroidism undergoing long term haemodialysis with vitamin D3
14. Considerations for the treatment of secondary hyperparathyroidism in renal failure
15. Report on the management of renal failure in Europe, XXIV, 1993
16. Registro Nacional de Dialisis y Transplante de la Sociedad Espanola de Nefrologia Informe 1993; Comite de Registro de la SEN
17. Bone disease in predialysis, hemodialysis and CAPD patients Evidence of a better bone response to PTH
18. EDTA-ERA Registry Report XXV, 1994. End-stage renal disease and dialysis report
19. Hyperkinetic azotemic osteodystrophy
20. Intact parathyroid hormone overestimates the presence and severity of parathyroid-mediated osseus abnormalities in uremia
21. Guidelines for dosing of intravenous calcitriol in dialysis patients with hyperparathyroidism
22. Cuales son los factores relacionados con la falta de respuesta al tratamiento?
23. The hyperparathyroidism of chronic renal failure: A disorder of growth
24. Osteodistrofia renal: Clasificacion y concepto actual